Strictureplasty for obstructive Crohn's disease: The Mayo experience

M. P. Spencer, Heidi Nelson, B. G. Wolff, R. R. Dozois

Research output: Contribution to journalArticle

55 Citations (Scopus)

Abstract

Background: Strictureplasty for obstructive Crohn's disease of the small bowel continues to gain favor throughout the world. Although the potential advantages of preserving intestinal length are obvious, the optimal clinical setting for performing strictureplasty remains to be determined. Patients: Of 244 patients who underwent abdominal exploration for complications of Crohn's disease between Jan. 1, 1985, and Jan. 1, 1991, at the Mayo Clinic, 35 had a total of 71 strictureplasties. Concomitant resection of bowel with active disease was performed in 67% of the procedures. Results: In this series, no perioperative deaths occurred, and no anastomotic leaks, enteric fistulas, or intra-abdominal abscesses were noted during a 3-year follow-up. The overall perioperative complication rate was 14%. Postoperatively, 33 of the 35 patients were able to resume enteral nutrition and discontinue medical treatments. The symptomatic recurrence rate at 3 years was 20%; six patients have required reoperation. Conclusion: These findings support the use of strictureplasty for isolated, quiescent, stenotic bowel lesions associated with Crohn's disease.

Original languageEnglish (US)
Pages (from-to)33-36
Number of pages4
JournalMayo Clinic Proceedings
Volume69
Issue number1
StatePublished - 1994

Fingerprint

Crohn Disease
Abdominal Abscess
Anastomotic Leak
Enteral Nutrition
Reoperation
Fistula
Recurrence
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Spencer, M. P., Nelson, H., Wolff, B. G., & Dozois, R. R. (1994). Strictureplasty for obstructive Crohn's disease: The Mayo experience. Mayo Clinic Proceedings, 69(1), 33-36.

Strictureplasty for obstructive Crohn's disease : The Mayo experience. / Spencer, M. P.; Nelson, Heidi; Wolff, B. G.; Dozois, R. R.

In: Mayo Clinic Proceedings, Vol. 69, No. 1, 1994, p. 33-36.

Research output: Contribution to journalArticle

Spencer, MP, Nelson, H, Wolff, BG & Dozois, RR 1994, 'Strictureplasty for obstructive Crohn's disease: The Mayo experience', Mayo Clinic Proceedings, vol. 69, no. 1, pp. 33-36.
Spencer, M. P. ; Nelson, Heidi ; Wolff, B. G. ; Dozois, R. R. / Strictureplasty for obstructive Crohn's disease : The Mayo experience. In: Mayo Clinic Proceedings. 1994 ; Vol. 69, No. 1. pp. 33-36.
@article{825390e9f01b4729887f4296476dc963,
title = "Strictureplasty for obstructive Crohn's disease: The Mayo experience",
abstract = "Background: Strictureplasty for obstructive Crohn's disease of the small bowel continues to gain favor throughout the world. Although the potential advantages of preserving intestinal length are obvious, the optimal clinical setting for performing strictureplasty remains to be determined. Patients: Of 244 patients who underwent abdominal exploration for complications of Crohn's disease between Jan. 1, 1985, and Jan. 1, 1991, at the Mayo Clinic, 35 had a total of 71 strictureplasties. Concomitant resection of bowel with active disease was performed in 67{\%} of the procedures. Results: In this series, no perioperative deaths occurred, and no anastomotic leaks, enteric fistulas, or intra-abdominal abscesses were noted during a 3-year follow-up. The overall perioperative complication rate was 14{\%}. Postoperatively, 33 of the 35 patients were able to resume enteral nutrition and discontinue medical treatments. The symptomatic recurrence rate at 3 years was 20{\%}; six patients have required reoperation. Conclusion: These findings support the use of strictureplasty for isolated, quiescent, stenotic bowel lesions associated with Crohn's disease.",
author = "Spencer, {M. P.} and Heidi Nelson and Wolff, {B. G.} and Dozois, {R. R.}",
year = "1994",
language = "English (US)",
volume = "69",
pages = "33--36",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "1",

}

TY - JOUR

T1 - Strictureplasty for obstructive Crohn's disease

T2 - The Mayo experience

AU - Spencer, M. P.

AU - Nelson, Heidi

AU - Wolff, B. G.

AU - Dozois, R. R.

PY - 1994

Y1 - 1994

N2 - Background: Strictureplasty for obstructive Crohn's disease of the small bowel continues to gain favor throughout the world. Although the potential advantages of preserving intestinal length are obvious, the optimal clinical setting for performing strictureplasty remains to be determined. Patients: Of 244 patients who underwent abdominal exploration for complications of Crohn's disease between Jan. 1, 1985, and Jan. 1, 1991, at the Mayo Clinic, 35 had a total of 71 strictureplasties. Concomitant resection of bowel with active disease was performed in 67% of the procedures. Results: In this series, no perioperative deaths occurred, and no anastomotic leaks, enteric fistulas, or intra-abdominal abscesses were noted during a 3-year follow-up. The overall perioperative complication rate was 14%. Postoperatively, 33 of the 35 patients were able to resume enteral nutrition and discontinue medical treatments. The symptomatic recurrence rate at 3 years was 20%; six patients have required reoperation. Conclusion: These findings support the use of strictureplasty for isolated, quiescent, stenotic bowel lesions associated with Crohn's disease.

AB - Background: Strictureplasty for obstructive Crohn's disease of the small bowel continues to gain favor throughout the world. Although the potential advantages of preserving intestinal length are obvious, the optimal clinical setting for performing strictureplasty remains to be determined. Patients: Of 244 patients who underwent abdominal exploration for complications of Crohn's disease between Jan. 1, 1985, and Jan. 1, 1991, at the Mayo Clinic, 35 had a total of 71 strictureplasties. Concomitant resection of bowel with active disease was performed in 67% of the procedures. Results: In this series, no perioperative deaths occurred, and no anastomotic leaks, enteric fistulas, or intra-abdominal abscesses were noted during a 3-year follow-up. The overall perioperative complication rate was 14%. Postoperatively, 33 of the 35 patients were able to resume enteral nutrition and discontinue medical treatments. The symptomatic recurrence rate at 3 years was 20%; six patients have required reoperation. Conclusion: These findings support the use of strictureplasty for isolated, quiescent, stenotic bowel lesions associated with Crohn's disease.

UR - http://www.scopus.com/inward/record.url?scp=0028069737&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028069737&partnerID=8YFLogxK

M3 - Article

C2 - 8271847

AN - SCOPUS:0028069737

VL - 69

SP - 33

EP - 36

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 1

ER -